ResMed Inc. (NYSE:RMD) Q3 2022 Earnings Conference Call April 28, 2022 4:30 PM ET Company Participants Amy Wakeham - VP, IR & Corporate Communications Mick Farrell - CEO Brett Sandercock - CFO Rob Douglas - President and COO Jim Hollingshead - President, Sleep & Respiratory Care business David Pendarvis - Chief Administrative Officer and Global General Counsel Conference Call Participants David Low - JPMorgan Gretel Janu - Credit Suisse Lyanne Harrison - Bank of America Saul Hadassin - Barrenjoey Dan Hurren ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________________________________________________________________________ FORM 10-Q ______________________________________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For ...

ResMed Inc. (NYSE:RMD) Q2 2022 Earnings Conference Call January 27, 2021 4:30 PM ET Company Participants Amy Wakeham - VP, IR & Corporate Communications Mick Farrell - CEO Brett Sandercock - CFO Rob Douglas - President and COO Jim Hollingshead - President, Sleep & Respiratory Care business David Pendarvis - Chief Administrative Officer and Global General Counsel Conference Call Participants Chris Cooper - Goldman Sachs Dan Hurren - MST Marquee Sean Laaman - Morgan Stanley Matthew Mishan - KeyBanc Craig Wong ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Delaware (State or other jurisdiction of incorporation or organization) 98-0152841 (I.R.S. Employer Identification No.) WASHINGTON, DC 20549 ______________________________________________________________________________________________ FORM 10-Q ______________________________________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly per ...

40th Annual J.P. Morgan Healthcare Conference Mick Farrell - CEO January 10, 2022 Presentation of financial information & forward-looking statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures ...

ResMed Inc. (NYSE:RMD) Q1 2022 Earnings Conference Call October 28, 2021 4:30 PM ET Company Participants Amy Wakeham - Vice President, Investor Relations & Corporate Communications Mick Farrell - Chief Executive Officer Brett Sandercock - Chief Financial Officer Rob Douglas - President and Chief Operating Officer Jim Hollingshead - President, Sleep & Respiratory Care business Conference Call Participants Matthew Mishan - KeyBanc Chris Cooper - Goldman Sachs David Low - JPMorgan Suraj Kalia - Oppenheimer Gre ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________________________________________________________________________ FORM 10-Q ______________________________________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 ...

ResMed Investor Day September 8, 2021 Forward Looking Statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures referred to as non-GAAP. The non-GAAP financial measures in this presentation, whic ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________________________________________________________________ FORM 10-K ______________________________________________________________________________________________ [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2021 Commission file number: 001-15317 _____________________________________________________________________________ ...

ResMed Inc. (NYSE:RMD) Q4 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Amy Wakeham - Vice President of Investor Relations and Corporate Communications Mick Farrell - Chief Executive Officer Brett Sandercock - Chief Financial Officer James Hollings - President, Sleep and Respiratory Care Business Rob Douglas - Chief Operating Officer Conference Call Participants John Deakin-Bell - Citi Investment Research Dan Hurren - MST Marquee David Bailey - Macquarie Sean Laaman - Morgan S ...